EyeGate Pharmaceuticals I...

NASDAQ: EYEG · Real-Time Price · USD
35.64
-0.07 (-0.20%)
At close: Aug 19, 2025, 3:59 PM
35.69
0.13%
After-hours: Aug 19, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
6.84M 9.03M -3.41M -10.43M -9.47M -8.72M
Depreciation & Amortization
-4.14K -4.46K -20.8K 43.32K 40.9K 36.93K
Stock-Based Compensation
392.85K 244.23K 171.18K 822.46K 860.72K 794.88K
Other Working Capital
-6.47M -6.47M -301.87K 12.02M 3.44M 2.61M
Other Non-Cash Items
10.93M 10.93M 2.45M -9.07M -791.4K 424.59K
Deferred Income Tax
-288.75K -288.75K n/a 12.05K 12.05K 12.05K
Change in Working Capital
-6.44M -6.44M 1.74M 9.44M 693.3K -34.79K
Operating Cash Flow
10.76M 13.47M 920.06K -9.19M -8.66M -7.49M
Capital Expenditures
-510 -510 n/a -83.94K -83.94K -78.2K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-39.25M -35.63M -7.8M n/a n/a n/a
Sales Maturities Of Investments
19.27M 12.98M 5.88M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -224.36K -224.36K -224.36K
Investing Cash Flow
-19.98M -22.66M -1.92M -308.3K -806.99K -801.24K
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-9.48M -9.48M n/a 17.74M 8.48M 9.03M
Financial Cash Flow
6.02M 6.02M n/a 17.74M 8.48M 9.03M
Net Cash Flow
-2.8M -2.78M -933.86K 8.18M -1.03M 732.51K
Free Cash Flow
10.76M 13.47M 920.06K -9.27M -8.74M -7.57M